{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:00Z","timestamp":1786120320561,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Platelet function disorders (PFDs) are caused by abnormalities in platelet receptors, granules, and signaling pathways. While severe conditions like Glanzmann Thrombasthenia (GT) and Bernard-Soulier Syndrome (BSS) have well-characterized bleeding phenotypes, other PFDs remain less defined. This study aimed to describe the bleeding phenotype in different PFDs at the time of diagnosis and during longitudinal follow-up and compare bleeding symptoms and health care utilization for bleed management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This retrospective multicenter study analyzed data from 129 patients diagnosed with PFDs at 3 Hemophilia Treatment Centers in the United States from 2015 to 2020. Data included demographics, bleeding symptoms, and treatment utilization. Statistical comparisons of bleeding symptoms, frequency, and treatment across PFDs were performed using the \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      or the Fisher exact tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 129 patients, 8 had GT, 2 had BSS, 40 had platelet storage pool disorder, 7 had platelet secretion defect, and 72 had PFD not otherwise specified (NOS). Epistaxis was the most common symptom at diagnosis, except in platelet secretion defects, where soft tissue bleeding predominated. Heavy menstrual bleeding affected 31.7% of females. Over a 5-year period, epistaxis remained frequent in GT and PFD NOS. GT had the highest treatment burden, with 86.2% of bleeds requiring treatment. Hospitalizations were significantly greater in GT and platelet secretion defects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Individuals with PFD NOS and platelet secretion defects can experience serious bleeding. Life-threatening bleeds occur in PFDs beyond GT and BSS, necessitating thorough evaluation, close follow-up, and careful perioperative planning. Unclassified platelet disorders require further evaluation along with genetic testing to prevent excessive blood loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003134","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:00:35Z","timestamp":1759780835000},"page":"e391-e397","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Unclassified Versus Well-defined Platelet Function Disorders: A Multicenter Comparison of Bleeding Patterns and Treatment"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7569-3118","authenticated-orcid":false,"given":"Divyaswathi","family":"Citla-Sridhar","sequence":"first","affiliation":[{"name":"University of Arkansas for Medical Sciences\/Arkansas Children\u2019s Hospital"},{"name":"Arkansas Children\u2019s Research Institute, Little Rock, AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Spray","sequence":"additional","affiliation":[{"name":"Arkansas Children\u2019s Research Institute, Little Rock, AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sidonio","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders, Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silvey","sequence":"additional","affiliation":[{"name":"Children\u2019s Mercy Hospital, Kansas City, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Ahuja","sequence":"additional","affiliation":[{"name":"University Hospitals Rainbow Babies and Children\u2019s Hospital, Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"R1-20251028","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1182\/asheducation-2013.1.268","article-title":"Inherited platelet disorders including Glanzmann thrombasthenia and Bernard-Soulier syndrome","volume":"2013","author":"Diz-K\u00fc\u00e7\u00fckkaya","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R2-20251028","first-page":"582","article-title":"Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine","volume":"88","author":"Balduini","year":"2003","journal-title":"Haematologica"},{"key":"R3-20251028","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.3390\/ijms22094521","article-title":"Inherited platelet disorders: an updated overview","volume":"22","author":"Palma-Barqueros","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R4-20251028","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.hoc.2013.02.005","article-title":"Inherited platelet function disorders: overview and disorders of granules, secretion, and signal transduction","volume":"27","author":"Rao","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"R5-20251028","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tmrv.2020.09.006","article-title":"Inherited platelet disorders: diagnosis and management","volume":"34","author":"Al-Huniti","year":"2020","journal-title":"Transfus Med Rev"},{"key":"R6-20251028","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.25910","article-title":"Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects","volume":"95","author":"Blaauwgeers","year":"2020","journal-title":"Am J Hematol"},{"key":"R7-20251028","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.12650","article-title":"Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey","volume":"12","author":"Gresele","year":"2014","journal-title":"J Thromb Haemost"},{"key":"R8-20251028","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1111\/jth.14974","article-title":"Standardizing care to manage bleeding disorders in adolescents with heavy menses\u2014a joint project from the ISTH pediatric\/neonatal and women\u2019s health SSCs","volume":"18","author":"Zia","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R9-20251028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2162-3619-2-3","article-title":"Clinical and laboratory characteristics of adolescents with platelet function disorders and heavy menstrual bleeding","volume":"2","author":"Amesse","year":"2013","journal-title":"Exp Hematol Oncol"},{"key":"R10-20251028","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/rth2.12374","article-title":"Bleeding risks for uncharacterized platelet function disorders","volume":"4","author":"Brunet","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"R11-20251028","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fcvm.2019.00080","article-title":"Inherited thrombocytopenia: update on genes and genetic variants which may be associated with bleeding","volume":"6","author":"Almazni","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"R12-20251028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bjh.12751","article-title":"What is the role of genetic testing in the investigation of patients with suspected platelet function disorders?","volume":"165","author":"Daly","year":"2014","journal-title":"Br J Haematol"},{"key":"R13-20251028","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/ijms18081803","article-title":"Platelet aggregometry testing: molecular mechanisms, techniques and clinical implications","volume":"18","author":"Koltai","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R14-20251028","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/ijlh.14136","article-title":"Platelet genetic testing by next-generation sequencing: a practical update","volume":"45","author":"Chen","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"R15-20251028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.2017.171132","article-title":"Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders","volume":"103","author":"Bastida","year":"2018","journal-title":"Haematologica"},{"key":"R16-20251028","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/jth.13681","article-title":"High-throughput sequencing approaches for diagnosing hereditary bleeding and platelet disorders","volume":"15","author":"Freson","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R17-20251028","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"Gresele","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R18-20251028","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood.2020009300","article-title":"Genetics of inherited thrombocytopenias","volume":"139","author":"Warren","year":"2022","journal-title":"Blood"},{"key":"R19-20251028","doi-asserted-by":"crossref","first-page":"100784","DOI":"10.1016\/j.blre.2020.100784","article-title":"Inherited thrombocytopenias: an updated guide for clinicians","volume":"48","author":"Pecci","year":"2021","journal-title":"Blood Rev"},{"key":"R20-20251028","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JBM.S71319","article-title":"Glanzmann\u2019s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options","volume":"6","author":"Solh","year":"2015","journal-title":"J Blood Med"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:05Z","timestamp":1786048145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003134","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"2025-03-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}